Localization of cardiac myosin specific antibody in myocardial infarction

Abstract

Specific localization of purified antibody against cardiac myosin has been demonstrated in areas of altered myocardial membrane permeability after experimental myocardial infarction. Intravenously administered radioiodine labeled antimyosin was selectively localized in infarcted myocardium of 7 dogs 24 hr after coronary occlusion. The mean ratio (±SE) of antimyosin antibody in infarcted to normal myocardium in the center of the infarct was 4.2±0.4 for endocardial and 2.9±0.3 for epicardial layers. By utilizing (Fab')2 fragments of antimyosin obtained by pepsin digestion of purified antibody, the ratio of uptake was increased in 8 dogs to 6.1±0.6 in the endocardial and 3.3±0.4 in the epicardial layers at the infarct center 24 hr after occlusion. These ratios were further increased in the infarct center to 13.8±1.2 in the endocardial and 7.3±0.8 in the epicardial layers when 8 dogs were sacrificed 72 hr after coronary occlusion. The specificity of antimyosin (Fab')2 localization in infarcted myocardium was demonstrated in 4 dogs by simultaneous intravenous administration of 125I labeled antimyosin (Fab')2 and 131I labeled normal rabbit gamma globulin (Fab')2. Nonspecific trapping of normal rabbit IgG (Fab')2 was observed to be about 38% of total antimyosin (Fab')2 uptake in the central zone of infarction. Regional blood flow was related to antimyosin (Fab')2 uptake in infarcted myocardium by utilizing simultaneous administration of 85Sr labeled microspheres. An inverse exponential relationship between antimyosin (Fab')2 uptake and regional blood flow was observed (r=0.85). The specific localization of antimyosin antibody or its (Fab')2 components in infarcted myocardium suggests a conceptually new approach to myocardial infarct localization and sizing.